| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-26 |
| filingDate |
2003-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b885a86aa5d3b86d012c5174210e29f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef3a1a780b4dc38e02fea61941b7b093
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c4e870f8d0aa1f05a645740ad5fe797
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68e94a4383692541706c0928014f98f1 |
| publicationDate |
2003-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003204096-A1 |
| titleOfInvention |
Enantioselective synthesis of azetidinone intermediate compounds |
| abstract |
The application relates to a process for preparing a compound of Formula I n n n This compound is an intermediate used to produce compounds that are useful as hypocholesterolemic agents in the treatment and prevention of atheroschlerosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9388440-B2 |
| priorityDate |
2002-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |